Beamtree Holdings Ltd · ASX:BMT

Beamtree — FY2026 Earnings Presentation

19 slides from Beamtree's earnings presentation, Aug 28, 2026

  1. Slide 1: FY26 Annual Results

    rsonal use only FY26 FY26 Annual Results 28th August 2026 Authorised for release by a duly authorised sub-committee of the Board

  2. Slide 2: rsonal use only

    > " - i; r > { >} fi bs} j \@ @s<* i = { ae a fa. s+ <4 as S at ® Beamtree 9Sn jeuosia

  3. Slide 3: Highlights

    Highlights Strategic Review completed rsonal use only Focus on high value Business process Product investment to products improvements drive growth Financial Performance Recurring Revenue up Positive Operating Profit Tight cost control 10.1% to $27.5m of $362k Balance Sheet Restructured Debt Write-d

  4. Slide 4: Helping healthcare providers deliver better care

    Helping healthcare providers deliver better care Our segments What we provide to support Healthcare delivery rsonal use only Software to audit the quality and accuracy of clinically coded information, enabling hospitals to Coding maximise complexity recognition and assure revenue received from payer

  5. Slide 5: Leading healthcare tech company focused on innovative AI

    Leading healthcare tech company focused on innovative AI enhanced solutions for coded data in the hospital and pathology markets rsonal use only Coding Analytics Diagnostics (30% of revenue) (42% of revenue) (28% of revenue) 73% >10k 100m+ Of acute patient records in Australia Unique benchmarks acro

  6. Slide 6: Leading healthcare tech company focused on innovative AI

    Leading healthcare tech company focused on innovative AI enhanced solutions for coded data in the hospital and pathology markets Coding Analytics Diagnostics rsonal use only 15 years of experience in Hospital clinical data coding Experts in Hospital and health systems analytics and Automation of cli

  7. Slide 7: Deep product capability

    Deep product capability Deep customer relationships Extensive domain expertise • Built for our Partner • Operational and clinical hospital data rsonal use only • Long term customers going back decades • High bar for accuracy • Standards and degrees of complexity which differ by geography Trusted hea

  8. Slide 8: Focused Markets

    Focused Markets ~25 rsonal use only Countries UNITED KINGDOM 68m population CANADA ~400 39m population Customers SAUDIA ARABIA 38m population +1200 Locations AUSTRALIA 27m population NEW ZEALAND 5m population Copyright © Beamtree Holdings Limited – All Rights Reserved 7

  9. Slide 9: FY26 Financial Results

    rsonal use only FY26 Financial Results

  10. Slide 10: Profit and Loss

    Profit and Loss FY25 FY26 FY26 Growth Recurring revenue up 10% High-quality recurring revenue makes up 95% of total rsonal use only Total Recurring Revenue 25.0 27.6 10% revenue. Low churn. Analytics 11.1 12.2 9% Clinical Decision support discontinued Diagnostics 7.5 7.9 6% Coding 5.9 7.2 21% Expens

  11. Slide 11: Recurring Revenue by Product and Geography

    Recurring Revenue by Product and Geography By Segment By Geography rsonal use only 27.5 27.5 0.3 25.0 25.0 0.5 7.0 7.6 +7% 27% 5.8 +21% 7.1 7.9 7.5 +6% 20.0 17.9 +11% 12.2 73% 11.1 +9% FY25 FY26 FY25 FY26 Analytics Diagnostics Coding Clinical Decision Support Australia & New Zealand International Co

  12. Slide 12: Balance Sheet

    Balance Sheet FY25 FY26 Intangibles assets $27.8m - $13.3m Goodwill impairment – $9.6m rsonal use only Current Assets Cash and cash equivalents 4.8 2.5 Software impairment - $3.6m Trade and other receivables 4.7 5.2 Contract assets 0.1 0.3 Total Current Assets 9.6 8.0 Borrowings Non-Current Assets C

  13. Slide 13: Cashflow

    Cashflow FY25 FY26 Variance Positive operating Cash flow Focus on working capital management rsonal use only Operating Activities Receipts from customers (inclusive of GST) 31.7 33.2 Payments to suppliers and employees (inclusive of GST) (31.1) (32.2) Interest received 0.0 0.1 Continue to invest in

  14. Slide 14: FY27 Priorities

    rsonal use only FY27 Priorities

  15. Slide 15: FY27 Priorities

    FY27 Priorities rsonal use only Priorities Execution & Focus Leverage our IP to bring value to our partners Continued focus on ARR growth through established & new products Copyright © Beamtree Holdings Limited – All Rights Reserved 14

  16. Slide 16: The partner between patient and healthcare provider

    rsonal use only The partner between patient and healthcare provider 15

  17. Slide 17: Thank you

    rsonal use only Thank you 16

  18. Slide 18: Beamtree - an Australian company with global reach.

    Beamtree - an Australian company with global reach. A leading healthcare technology company focused on innovative AI enhanced solutions for data quality assurance in the hospital, benchmarking to promote best practice, and automation in diagnostics care. rsonal use only Hospital clinical coding tool

  19. Slide 19: Important Notice and Disclaimer

    Important Notice and Disclaimer The material in this presentation is general background information about Beamtree Holdings Limited (ASX:BMT) and is current at the date of the rsonal use only presentation, August 2026. This presentation may contain statements that are, or may be deemed to be, forwar

Beamtree Holdings — FY2026 Earnings Presentation on 6ix